UnratedDrug recall · FDA · Published August 29, 2019
Preferred Pharmaceuticals recalls 180mg Fexofenadine tablets due to impurities
Preferred Pharmaceuticals recalls 180mg Fexofenadine HCl tablets (NDC 68788-6848-09) with failed impurities specifications. Consumers should contact the company for details.
“Preferred Pharmaceuticals recalls 180mg Fexofenadine tablets due to impurities.” GovInfoNow, updated October 5, 2026. https://govinfonow.com/recall/38064-preferred-pharmaceuticals-recalls-180mg-fexofenadine-tablets-due-to-impurities. Based on FDA recall #D-1877-2019 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-1877-2019%22&limit=1).
The FDA announced on August 29, 2019, that Preferred Pharmaceuticals, Inc. voluntarily recalled Fexofenadine HCl Tablets due to failed impurities and degradation specifications. The recall affects 79 bottles distributed to a single physician in Gainesville, Florida.
The recall was issued because the Fexofenadine HCl Tablets failed impurities and degradation specifications. The FDA classified this as a Class II recall.
Context
GovInfoNow's records show Preferred Pharmaceuticals, Inc. has 32 other recalls on record since August 15, 2018. Other recent recalls of similar products include Preferred Pharma Recalls Lidocaine Ointment Due to Content Issues (September 28, 2026), Geri-Care Eye Drops Recalled for Sterility Risk (March 25, 2026), and Preferred Pharma Recalls Ondansetron ODT Due to Defective Seals (November 17, 2025). Other recent recalls of similar products include Sun Pharmaceutical Fexofenadine 180mg Tablets Recall: Impurities Risk Safety (June 1, 2026), Ajanta Pharma Fluphenazine Tablets Recall: Impurity Risk in 100-Count Bottles (August 25, 2026), and Sun Pharmaceutical Fluocinolone Acetonide Solution Recall: Impurity Risk (December 30, 2025).
How to tell if you have this one
Check for the product name 'Fexofenadine HCl Tablets, 180 mg, Pkg Size 90', manufacturer 'Aurohealth LLC', and lot number 'G0219K' with expiration date 3/2021.
Brand
Preferred Pharmaceuticals
Category
Drug
Based on the official FDA remedy
What to do — step by step
Check Product Details
Look for the lot number 'G0219K' and expiration date 3/2021 on the packaging.
Where it went and when
Where it was distributed
Distributed in Florida.
Listed by the agency
Not listed
FDA distribution: “Product was distributed to 1 physician in Gainesville Florida.” States read from FDA’s own wording; “not listed” means the notice does not name it.
States: Florida.
Recall timeline
FDA terminated this recall 3.7 years after the firm started it.
1Firm started the recall
2FDA classified it Class II
3Published in FDA’s Enforcement Report
4FDA terminated the recall
Dates from the agency record only; steps without a date are left out.
The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.
Official source: FDA Recall #D-1877-2019 (August 29, 2019) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-1877-2019 to see it in context.
Plain-language summary written by qwen3:4b on October 5, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.